| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 426 |
| 1 | RIVAROXABAN | 409 |
| 2 | ASPIRIN | 375 |
| 3 | METFORMIN | 359 |
| 4 | ASPIRIN 325 MG | 346 |
| 5 | ASPIRIN 81 MG | 346 |
| 6 | METFORMIN ER 500 MG | 289 |
| 7 | METFORMIN ER 750 MG | 289 |
| 8 | OMEPRAZOLE MAGNESIUM | 227 |
| 9 | PANTOPRAZOLE | 221 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDARUCIZUMAB | 13 | 0.0091 |
| 1 | COAGULATION FACTOR VIIA (RECOMBINANT) | 15 | 0.0055 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 46 | 0.0055 |
| 3 | MITOTANE | 10 | 0.0055 |
| 4 | FONDAPARINUX SODIUM | 43 | 0.0053 |
| 5 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 20 | 0.0044 |
| 6 | CLINDAMYCIN PHOSPHATE | 20 | 0.0036 |
| 7 | LOXAPINE | 13 | 0.0033 |
| 8 | DOPAMINE HYDROCHLORIDE | 12 | 0.0032 |
| 9 | DABIGATRAN ETEXILATE MESYLATE | 209 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 672 |
| 1 | Factor Xa Inhibitor [EPC] | 594 |
| 2 | Corticosteroid [EPC] | 562 |
| 3 | Loop Diuretic [EPC] | 490 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 383 |
| 5 | Proton Pump Inhibitor [EPC] | 346 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 321 |
| 7 | Platinum-based Drug [EPC] | 283 |
| 8 | Benzodiazepine [EPC] | 273 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 247 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lysosomal beta Glucuronidase [EPC] | 1 | 0.0156 |
| 1 | Humanized Monoclonal Antibody Fragment [EPC] | 13 | 0.0091 |
| 2 | Aldehyde Dehydrogenase Inhibitor [EPC] | 8 | 0.0070 |
| 3 | Sclerosing Agent [EPC] | 3 | 0.0067 |
| 4 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 2 | 0.0051 |
| 5 | Endoglycosidase [EPC] | 9 | 0.0049 |
| 6 | Antidiarrheal [EPC] | 1 | 0.0042 |
| 7 | Macrolide Antibacterial [EPC] | 4 | 0.0040 |
| 8 | Lymphocyte Activation Gene-3 Blocker [EPC] | 2 | 0.0039 |
| 9 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |